
Bavarian Nordic confirms buyout talks with private equity firms amid new chikungunya threats
Just as new outbreaks of chikungunya threaten to become another epidemic, Bavarian Nordic, maker of a vaccine against the mosquito-borne virus, has entered discussions of a potential buyout. Bavarian Nordic confirmed Thursday that the company is in talks …